Clinical Trial Update: PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports the completion of the PULSAR study evaluating low doses of atorvastatin and rosuvastatin for hypercholesterolaemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolaemia

Drugs mentioned

• CRESTOR (Rosuvastatin)
• Lipitor (atorvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolaemia | Phase 3 | Status: COMPLETED